Classical and new approaches in laboratory diagnosis of viridans streptococci;Vi̇ri̇dans streptokoklarin laboratuvar tanisinda klasi̇k ve yeni̇ yaklaşimlar

Mikrobiyoloji Bulteni

Volumn 44, Issue 3, 2010, Pages 495-503

  Ergin, Alper ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Alpha hemolytic streptococci; Classification; Identification; Mitis group streptococci; Viridans streptococci

Indexed keywords

ALPHA HEMOLYTIC STREPTOCOCCUS; BACTERIUM IDENTIFICATION; CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MOLECULAR TYPING; PHYLOGENY; REVIEW; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

BACTERIAL TYPING TECHNIQUES; DIAGNOSIS, DIFFERENTIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR TYPING; PHYLOGENY; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; VIRIDANS STREPTOCOCCI;

EID: 77956356457     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Shenep JL, Viridans-group streptococcal infections in immunocompromised hosts. Int J Antimicrob Agents 2000;14:129-35.
2. Bruckner L,'Gigliotti F. Viridans group streptococcal infections among children with cancer and the importance of emerging antibiotic resistance. Semin Pediatr Infect Dis 2006; 17: 153-60.
3. Paganini H, Staffolani V, Zubizerrata P, et al. Viridans streptococci bacteremia in children with fever and neutrppenia: a case-control study of predisposing factors. Eur J Cancer 2003; 39: 1284-9.
4. Facklam R. What happened to the streptococci: overview of taxonomie and nomenclature changes. Clin Microbiol Rev 2002; 15: 613-30.
5. Balsalobre L, Hernandez-Madrid A, Llull D, et al. Molecular characterization of disease-associated streptococci of the mitis group that are optochin susceptible. J Clin Microbiol 2006; 44: 4163-71.
6. Kilian M, Poulsen. K, Blomqvist T, et al. Evolution of Streptococcus pneumoniae and its close commensal relatives. PLoS One 2008; 3: e2683.
7. Arbique JC, Poyart C, Trieu-Cuot P, et al. Accuracy of phenotypic and genotypic testing for identification of Streptococcus pneumoniae and description of Streptococcus pseudopneumoniae sp. nov. J Clin Microbiol 2004; 42: 4686-96.
8. Berkiten R. Streptococcus pneumoniae. Klasik ve moleküler tanida karşilaşilan sorunlar. ANKEM 2006; 20: 180-6.
9. Kiratisin P. The role of gene analysis for species determination of viridans streptococci. Clin Microbiol Newsletter 2003; 25: 169-73.
10. th ed. Churchill Livingstone, Philadelphia.
11. Donay JL, Mathieu D, Fernandes P, et al. Evaluation of the automated Phoenix system for potential routine use in the clinical microbiology laboratory. J Clin Microbiol 2004; 42: 1542-6.
12. Brigante G, Luzzaro F, Bettaccini A, et al. Use of the Phoenix automated system for identification of Streptococcus and Enterococcus spp. J Clin Microbiol 2006; 44: 3263-7.
13. Gavin PJ, Warren JR, Obias AA, Collins SM, Peterson LR. Evaluation of the Vitek 2 system for rapid identification of clinical isolates of gram-negative bacilli and members of the family Streptococcaceae. Eur J Clin Microbiol Infect Dis 2002; 21: 869-74.
14. Garnier F, Gerbaud G, Courvalin P, Galimand M. Identification of clinically relevant viridans group streptococci to the species level by PCR. J Clin Microbiol 1997; 35: 2337-41.
15. Teng LJ, Hsueh PR, Tsai JC, et al. groESL sequence determination, phylogenetic analysis, and species differentiation for viridans group streptococci. J Clin Microbiol 2002; 40: 3172-8.
16. Poyart C, Quesne G, Coulon S, Berche P, Trieu-Cuot P. Identification of streptococci to species level by sequencing the gene encoding the manganese-dependent superoxide dismutase. J Clin Microbiol 1998; 36: 41-7.
17. Kiratlsin P, Li L, Murray P, Fischer SH. Use of housekeeping gene sequencing for species identification of viridans streptococci. Diagn Microbiol Infect Dis 2005; 51: 297-301.
18. Simmon KE, Hall L, Woods WC, et al. Phylogenetic analysis of viridans group streptococci causing endocarditis. J Clin Microbiol 2008; 46: 3087-90.
19. th Informational Supplement. M100-S18. 2008. CLSI, Wayne, PA.
20. Ondrusova A, Liskova A, Miklosko J, et al. Resistance to penicillin and erythromycin in viridans streptococcal bloodstream isolates from cancer and non-cancer patients within 10 years. Infect Control Hosp Epidemiol 2004; 25: 365-7.
21. Smith A, Jackson MS, Kennedy H. Antimicrobial susceptibility of viridans group streptococcal blood isolates to eight antimicrobial agents. Scand J Infect Dis 2004; 36: 259-63.
22. Lyytikainen O, Rautio M, Carlson P, et al. Nosocomial bloodstream infections due to viridans streptococci in haematological and non-haematological patients: species distribution and antimicrobial resistance. J Antimicrob Chemother 2004; 53: 631-4.
23. Potgieter E, Carmicheal M, Koornhof HJ, Chalkley LJ. in vitro antimicrobial susceptibility of viridans streptococci isolated from blood cultures. Eur J Clin Microbiol Infect Dis 1992; 11: 543-6.
24. Ergin A, Ercis S, Hasçelik G. Macrolide resistance mechanisms and in vitro susceptibility patterns of viridans group streptococci isolated from blood cultures. J Antimicrob Chemother 2006; 57: 139-41.
25. Paulus S, Dobson S, Rassekh S, Blondel-Hill E. In vitro inferiority of ceftazidime compared with other betalactams for viridans group Streptococcus bacteremia in pediatric oncology patients. J Pediatr Hematol Oncol 2009; 31: 267-9.
26. Brown DFJ, Hope R, Livermore D, et al. Non-susceptibility trends among enterococci and non-pneumococcal streptococci from bacteremias in the UK and Ireland, 2001-06. J Antimicrob Chemother 2008; 62 (Suppl 2): ii75-85.